RecruitingPhase 4NCT06865885

LDL-C Optimization Using Inclisiran in Patients in Which Drug-Drug Interactions Limit LDL Lowering

Studying C syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of California, San Diego
Principal Investigator
Michael Wilkinson, MD
University of California, San Diego
Intervention
Inclisiran sodium 300 mg (equivalent to 284 mg inclisiran) in 1.5 mL(drug)
Enrollment
100 enrolled
Eligibility
18-85 years · All sexes
Timeline
20252026

Study locations (1)

Collaborators

Novartis

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06865885 on ClinicalTrials.gov

Other trials for C syndrome

Additional recruiting or active studies for the same condition.

See all trials for C syndrome

← Back to all trials